---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001486"
form_type: "8-K"
ticker: "ACBM"
cik: "0001622996"
company_name: "ACRO BIOMEDICAL CO., LTD."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:13:25.097098+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ACRO Biomedical appoints Yu-Ting Su as CEO and chairman; Pao-Chi Chu resigns

## Summary
- Pao-Chi Chu resigned as director, chairman and CEO effective upon successor's appointment; resignation not due to any disagreement.
- Board appointed Yu-Ting Su as director, chairman and CEO effective August 14, 2025.
- Ms. Su previously served as VP of cell banking division at BioSpring Co., Ltd. (Jan 2023 - Aug 2025) and VP at BioSeed Co., Ltd. (Aug 2020 - Dec 2022).

## SEC filing metadata
- accession: 0001640334-25-001486
- form_type: 8-K
- ticker: ACBM
- cik: 0001622996
- company_name: ACRO BIOMEDICAL CO., LTD.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1622996/000164033425001486/0001640334-25-001486-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1622996/000164033425001486/acbm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001486
- JSON: https://secwatch.observer/filing/0001640334-25-001486.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001486.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.